IDO1 and neoplasm: A library of heat- and ROS-sensitive peptide hydrogels was developed for sustained delivery of aPD-L1 and IDO inhibitors and to modulate ROS levels in the tumor microenvironment to facilitate the release of immunotherapeutic drugs